Authors: Dr. Chandani Rawat, Piyush Jain, Abhishek Mehta
Abstract: Pharmacovigilance is becoming more prevalent in India. Given the scale of the Indian pharmaceutical business, it is critical to understand how pharmacovigilance affects pharmaceutical goods. Pharmacovigilance contributes to the safe use of pharmaceutical products, however under reporting is a big issue in India, either to a lack of information or a fear of the unknown. To develop a strong pharmacovigilance system in India, both the Indian pharmaceutical industry and the government must participate actively. Initiatives that can aid tiny privatised generic enterprises in dealing with changing laws, given their low budget, are required. This article presents an overview of India's current pharmacovigilance system, its difficulties, and how those problems can be overcome if India adopts the pharmacovigilance procedures used by other developed and developing countries.
Keywords: Adverse Drug Reaction, Central Drugs Standard Control Organization, Pharmacovigilance,
Full Issue
| View or download the full issue | PDF 31-44 |